- Home
- PLX vs COE Comparison
PLX vs COE Comparison
Compare PLX & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- COE
- Stock Information
- Founded
- PLX 1993
- COE 2011
- Country
- PLX United States
- COE Singapore
- Employees
- PLX N/A
- COE N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- COE Other Consumer Services
- Sector
- PLX Health Care
- COE Real Estate
- Exchange
- PLX Nasdaq
- COE Nasdaq
- Market Cap
- PLX 122.6M
- COE 117.5M
- IPO Year
- PLX 1998
- COE 2016
- Fundamental
- Price
- PLX $1.40
- COE $29.67
- Analyst Decision
- PLX Strong Buy
- COE
- Analyst Count
- PLX 1
- COE 0
- Target Price
- PLX $15.00
- COE N/A
- AVG Volume (30 Days)
- PLX 640.7K
- COE 20.4K
- Earning Date
- PLX 08-13-2025
- COE 06-09-2025
- Dividend Yield
- PLX N/A
- COE N/A
- EPS Growth
- PLX N/A
- COE N/A
- EPS
- PLX 0.05
- COE N/A
- Revenue
- PLX $59,764,000.00
- COE $59,490,000.00
- Revenue This Year
- PLX $65.02
- COE N/A
- Revenue Next Year
- PLX $57.34
- COE N/A
- P/E Ratio
- PLX $28.96
- COE N/A
- Revenue Growth
- PLX 0.18
- COE 91.87
- 52 Week Low
- PLX $0.82
- COE $9.33
- 52 Week High
- PLX $3.10
- COE $31.96
- Technical
- Relative Strength Index (RSI)
- PLX 30.38
- COE 72.86
- Support Level
- PLX $1.52
- COE $25.75
- Resistance Level
- PLX $1.65
- COE $29.88
- Average True Range (ATR)
- PLX 0.08
- COE 2.29
- MACD
- PLX 0.02
- COE 0.35
- Stochastic Oscillator
- PLX 17.19
- COE 75.66
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.